/

Empresas

Ve

No verificado

Veradermics

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosSaludSanidad

4 Comunicados de prensa

Ver todos los comunicados de prensa

11/12/2025

Veradermics Completes Enrollment in its Phase 2/3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss, Advancing Development of the Potential First-Ever Extended-Release Oral Minoxidil

Fuente

Editor

1.00

0

18/11/2025

Industria

Biotecnología

Sanidad

Salud

Farmacéutica

Medicina - Varios

Veradermics Advances VDPHL01 in Phase 2/3 Clinical Trial for Female Pattern Hair Loss, Marking a Milestone in the Development of the Potential First-Ever Oral Prescription Treatment for Women

Fuente

Editor

1.00

0

16/10/2025

Veradermics Announces Oversubscribed $150 Million Series C Financing to Advance VDPHL01 Through Multiple Phase 3 Trials as Potentially the First Non-Hormonal Oral Therapeutic for Hair Regrowth in Women and Men

Fuente

Editor

1.00

0

11/12/2024

Mercado laboral

Salud

Sanidad

Medicina - Varios

Farmacéutica

Biotecnología

Veradermics Raises $75 Million in Series B Financing and Initiates Phase 2/3 Trial for Hair Loss

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0